Clareo Biosciences is advancing immunosequencing by applying Pacific Biosciences' HiFi long-read technology to capture comprehensive adaptive immune receptor repertoires at the DNA and RNA levels. Their GenotypAIR assay enables precise genomic characterization of highly diverse immune loci, enriching understanding beyond RNA-based approaches. Using peripheral blood mononuclear cells and other sample types, Clareo's platform addresses complexity in immune genetics to facilitate diagnostic, therapeutic, and vaccine development applications.